Shawn R. Lockhart spends much of his time researching Microbiology, Candida albicans, Fluconazole, Candida glabrata and Caspofungin. His Gene research extends to Microbiology, which is thematically connected. His study in Candida albicans is interdisciplinary in nature, drawing from both Phenotype, Mating type and Cell biology.
His biological study spans a wide range of topics, including Multiple drug resistance, Epidemiology and Candida auris. His Candida glabrata research incorporates themes from Antifungal drug and Incidence. The various areas that he examines in his Caspofungin study include Candida parapsilosis and Micafungin.
Shawn R. Lockhart mostly deals with Microbiology, Candida auris, Cryptococcus gattii, Fluconazole and Genetics. Micafungin, Candida glabrata, Caspofungin, Anidulafungin and Echinocandin are among the areas of Microbiology where Shawn R. Lockhart concentrates his study. The concepts of his Candida auris study are interwoven with issues in Multiple drug resistance, Drug resistance, Outbreak and Infection control.
His Cryptococcus gattii study combines topics in areas such as Ecology and Virology. The Fluconazole study combines topics in areas such as Candida parapsilosis, Amphotericin B, Internal medicine, Epidemiology and Voriconazole. His research investigates the connection between Candida albicans and topics such as DNA profiling that intersect with issues in Southern blot.
His primary areas of investigation include Candida auris, Microbiology, Antifungal, Outbreak and Intensive care medicine. The study incorporates disciplines such as Multiple drug resistance, Drug resistance, Yeast, Internal medicine and Fungus in addition to Candida auris. His is involved in several facets of Microbiology study, as is seen by his studies on Fluconazole, Broth microdilution, Amphotericin B, Echinocandins and Caspofungin.
His studies link Candida parapsilosis with Fluconazole. His Caspofungin research focuses on Echinocandin and how it relates to Micafungin, In vitro, Voriconazole and Itraconazole. His Outbreak research is multidisciplinary, incorporating elements of Epidemiology, Infection control, Whole genome sequencing, Transmission and Disease cluster.
His main research concerns Candida auris, Outbreak, Antifungal, Antifungal drug and Immune system. His study with Candida auris involves better knowledge in Microbiology. His Candida albicans and Micafungin investigations are all subjects of Microbiology research.
His work deals with themes such as Mortality rate, Infection control and Fungus, which intersect with Outbreak. In his work, Clinical microbiology is strongly intertwined with Broth dilution, which is a subfield of Antifungal drug. His Multiple drug resistance study integrates concerns from other disciplines, such as Amphotericin B, Fluconazole and Echinocandins.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Revision and Update of the Consensus Definitions of Invasive Fungal Disease From the European Organization for Research and Treatment of Cancer and the Mycoses Study Group Education and Research Consortium
J. Peter Donnelly;Sharon C. Chen;Carol A. Kauffman;William J. Steinbach.
Clinical Infectious Diseases (2020)
Simultaneous Emergence of Multidrug-Resistant Candida auris on 3 Continents Confirmed by Whole-Genome Sequencing and Epidemiological Analyses
Shawn R. Lockhart;Kizee A. Etienne;Snigdha Vallabhaneni;Joveria Farooqi.
Clinical Infectious Diseases (2017)
Antimicrobial Resistance among Gram-Negative Bacilli Causing Infections in Intensive Care Unit Patients in the United States between 1993 and 2004
Shawn R. Lockhart;Murray A. Abramson;Susan E. Beekmann;Gale Gallagher.
Journal of Clinical Microbiology (2007)
Frequency of Decreased Susceptibility and Resistance to Echinocandins among Fluconazole-Resistant Bloodstream Isolates of Candida glabrata
M. A. Pfaller;M. Castanheira;S. R. Lockhart;A. M. Ahlquist.
Journal of Clinical Microbiology (2012)
Changes in Incidence and Antifungal Drug Resistance in Candidemia: Results From Population-Based Laboratory Surveillance in Atlanta and Baltimore, 2008–2011
Angela Ahlquist Cleveland;Monica M. Farley;Lee H. Harrison;Betsy Stein.
Clinical Infectious Diseases (2012)
Clinical breakpoints for the echinocandins and Candida revisited: Integration of molecular, clinical, and microbiological data to arrive at species-specific interpretive criteria
M.A. Pfaller;D.J. Diekema;D. Andes;M.C. Arendrup.
Drug Resistance Updates (2011)
Changes in the epidemiological landscape of invasive candidiasis
Frederic Lamoth;Shawn R Lockhart;Elizabeth L Berkow;Thierry Calandra.
Journal of Antimicrobial Chemotherapy (2018)
Species Identification and Antifungal Susceptibility Testing of Candida Bloodstream Isolates from Population-Based Surveillance Studies in Two U.S. Cities from 2008 to 2011
Shawn R. Lockhart;Naureen Iqbal;Angela A. Cleveland;Monica M. Farley;Monica M. Farley.
Journal of Clinical Microbiology (2012)
Investigation of the First Seven Reported Cases of Candida auris, a Globally Emerging Invasive, Multidrug-Resistant Fungus - United States, May 2013-August 2016.
Snigdha Vallabhaneni;Alex Kallen;Sharon Tsay;Nancy Chow.
Morbidity and Mortality Weekly Report (2016)
Fluconazole resistance in Candida species: a current perspective
Elizabeth L Berkow;Shawn R Lockhart.
Infection and Drug Resistance (2017)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: